SCHEMBL30255462

SCHEMBL30255462

Cc1cccc(C)c1-c1c(F)cc(Cl)c(C=O)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 2/20 0.35
GRIA1 P42261 2/20 0.33
CACNG8 Q8WXS5 2/20 0.33
MAPT P10636 2/20 0.32
KDM4E B2RXH2 1/20 0.32
RECQL P46063 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
PTGS1 P23219 4/20 0.31
PTGS2 P35354 4/20 0.31
PKM P14618 1/20 0.31
ERN1 O75460 1/20 0.31
ACHE P22303 1/20 0.31
RAPGEF4 Q8WZA2 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24028007 0.72 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ATDP1TSHR
SCHEMBL28947161 0.69 ERN1 (0.42) ALDH1A1MEN1KMT2ATDP1TSHR
SCHEMBL15621301 0.68 AR (0.47) ALDH1A1MEN1KMT2ATDP1PTGS2
SCHEMBL1663012 0.68 ACHE (0.48) ALDH1A1MEN1KMT2ATDP1TSHR
SCHEMBL910073 0.68 ALDH1A1 (0.70) ALDH1A1MEN1KMT2ATDP1TSHR
SCHEMBL31227003 0.68 ACHE (0.48) ALDH1A1MEN1KMT2ATDP1TSHR
SCHEMBL1133242 0.68 MYC (0.34) ALDH1A1MEN1KMT2ATDP1TSHR
SCHEMBL15543777 0.65 ALDH1A1 (0.37) ALDH1A1MEN1KMT2ATDP1MAPT
SCHEMBL19682803 0.65 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ATDP1MAPT
SCHEMBL21196268 0.65 MEN1 (0.33) ALDH1A1MEN1KMT2ATDP1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149928-A1 IMIDAZOLE 3-OXIDE DERIVATIVE BASED ACSS2 INHIBITORS AND METHODS OF USE THEREOF Metabomed Ltd (IL) 2023-03-22 EP disclosed